Cited by 67Psychotherapy Techniques and ApplicationsTreatment of Major DepressionPsychological Treatments and Disorders

Psychotherapy as an epigenetic 'drug': Psychiatric therapeutics target symptoms linked to malfunctioning brain circuits with psychotherapy as well as with drugs

Open access
Stahl, S. M.·2012·Journal of Clinical Pharmacy and Therapeutics

Abstract

WHAT IS KNOWN AND OBJECTIVE: Psychotherapy has traditionally competed with psychopharmacology. As drugs have become the more dominant treatment in psychiatry and primary care, this approach is increasingly criticized as limited in scope, lacking in robust outcomes and too heavily influenced by the pharmaceutical industry. Our objective is to show that recent advances in neurobiology are clarifying that learning and environmental experiences, such as psychotherapy, change brain circuits as do drugs. The leading notion of how therapeutic effects occur in psychiatric disorders is that they happen when symptoms are reduced by improving the efficiency of information processing in hypothetically malfunctioning brain circuits. COMMENT: With this formulation of psychiatric symptoms and their relief, it is not surprising that both psychotherapy and psychopharmacology can be clinically effective for treating psychiatric disorders, or indeed that combining them can be therapeutically synergistic. Psychotherapy, including a new spinoff of cognitive behavioural therapy called trial-based therapy, like many other forms of learning, can hypothetically induce epigenetic changes in brain circuits that can enhance the efficiency of information processing in malfunctioning neurons to improve symptoms in psychiatric disorders, just like drugs. WHAT IS NEW AND CONCLUSION: Psychotherapies can be conceptualized as epigenetic 'drugs', or at least as therapeutic agents that act epigenetically in a manner similar or complementary to drugs. These findings are leading to a paradigm shift in psychiatry such that psychotherapy is experiencing a come-back as various standardized, brief, goal-directed psychotherapies are being integrated with drug treatment of psychiatric disorders by psychopharmacologists who have traditionally relied on a drugs-only approach.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2710.2011.01301.x

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. [1]1. Stahl SM (2008) Stahls essential psychophar- macology, 3rd edn. New York: Cambridge University Press.
  2. [2]2. Stahl SM Psychiatric stress testing: novel strategy for translatrionsl psychopharma- cology. Neuropsychopharmacology, 2010;35:1413-1414.
  3. [14]14. De Oliveira IR (2011) Trial-based thought record: accepted entry in common language for psychotherapy procedures. Available at: http://www.commonlanguagepsychother- apy.org. (accessed 25 July 2011). ª 2011 Blackwell Publishing Ltd Journal of Clinical Pharmacy and Therapeutics, 2012, 37, 249-253 253 Psychotherapy as an epigenetic 'drug' S. M. Stahl 13652710, 2012, 3,

Authors
Stahl, S. M.
Affiliations
University of Cambridge (GB)
Corresponding author
Stahl, S. M.
Venue
Journal of Clinical Pharmacy and Therapeutics
Published
2011-10-10
Volume
37
Issue
3
Pages
249-253
ISSN
0269-4727 (ISSN-L)
OpenAlex
W1647255995
Cited by
67
References
14
Citations by year
2026: 3 · 2025: 1 · 2024: 5 · 2023: 1 · 2022: 7 · 2021: 3 · 2020: 9 · 2019: 3 · 2018: 3 · 2017: 1 · 2016: 8 · 2015: 2 · 2014: 6 · 2013: 6 · 2012: 9
FWCI
7.24
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Pharmacy and Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Social Sciences › Psychology › Clinical Psychology › Psychological Treatments and Disorders
Keywords
psychotherapy, epigenetics, brain circuits, psychopharmacology, psychiatric treatment, cognitive behavioral therapy, information processing, psychiatric symptoms, combination therapy, brief psychotherapy
MeSH terms
Amygdala, Animals, Mental Disorders, Combined Modality Therapy, Humans, Neurons, Psychiatry, Psychotherapy, Psychotropic Drugs, Cognitive Behavioral Therapy, Epigenesis, Genetic, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review